NCT07647627|Unknown
Availability of Dibotatug (DR-01) Outside Clinical Trials Via Expanded Access for Eligible Participants
1 other identifier
Dibotatug EAP
Study Type
expanded_access
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredJun 2026
Brief Summary
This is an expanded access program (EAP) for eligible participants designed to provide access to Dibotatug (DR-01). Physician-requested expanded access will generally only be considered for patients not otherwise eligible for an ongoing clinical study sponsored by Dren Bio and provided that other program eligibility criteria are also met.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2026
Completed6 days until next milestone
First Posted
Study publicly available on registry
June 15, 2026
CompletedLast Updated
June 15, 2026
Status Verified
June 1, 2026
First QC Date
June 9, 2026
Last Update Submit
June 9, 2026
Interventions
DibotatugDRUG
Also known as: DR-01
Sponsors & Collaborators
- Dren Biolead
Central Study Contacts
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2026
First Posted
June 15, 2026
Last Updated
June 15, 2026
Record last verified: 2026-06